US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% SNDK $1,704.16 ▼-0.92%
FinancialContent

Articles published by Cytek Biosciences, Inc.

< Previous 1 2 Next >
News headline image
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences Reports First Quarter 2025 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences Announces $50 Million Stock Repurchase Program
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences Reports First Quarter 2024 Financial Results
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Names William McCombe Chief Financial Officer
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
News headline image
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
From Cytek Biosciences, Inc.
Via GlobeNewswire
Tickers CTKB
< Previous 1 2 Next >